Unichem Laboratories Ltd Financials
Company Logo

Unichem Laboratories Ltd Financial Statement

Unichem Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue443.96
Operating Expense372.38
Net Profit43.37
Net Profit Margin9.77
Earning Per Share6.16
EBIDTA71.58
Effective Tax RateTBA
Invest in Unichem Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Unichem Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,442.17
Operating Expenses Annual1,391.25
Operating Profit Annual23.70
Interest Annual10.42
Depreciation105.46
Net Profit Annual-92.18
Tax AnnualTBA

Unichem Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning155.67
Cash Flow from Operations-41.57
Cash Flow from Investing59.61
Cash Flow from Financing-48.06
Cash Flow at the End125.65

Unichem Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)5.52
PBIT Margin (%)-1.79
PBT Margin (%)-1.62
Net PROFIT Margin (%)-6.39
Return On Networth / Equity (%)-1.55
Return On Networth /Employed (%)-1.05
Return On Assets (%)-3.71
Total Debt / Equity (X)0.04
Asset Turnover Ratio (%)0.58

Unichem Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,164.94
Total Current Assets Annual1,406.13
Non Current Assets Annual1,454.22
Total Shareholders Funds Annual2,294.63
Total Assets Annual2,863.70

Unichem Laboratories Ltd Earning Calls

EPS (INR)

Expected

4.33

Reported

4.34

Surprise

0.23%

Jun 2024

EPS beaten by 0.23%

Mar 2024

EPS beaten by -0.76%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 23, 2024, Unichem Laboratories Ltd has a market capitalization of 3,439.32 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Unichem Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Unichem Laboratories Ltd recorded a total revenue of approximately 1,442.17 Cr marking a significant milestone in the company's financial performance.
Unichem Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.2% annually, respectively..
Unichem Laboratories Ltd's current PE ratio is -37.31.
Unichem Laboratories Ltd's ROCE averaged -3.4% from the FY ending March 2022 to 2024, with a median of -3.0%. It peaked at -1.0% in March 2024, reflecting strong capital efficiency over the period..
Unichem Laboratories Ltd's latest EBIT is Rs. -81.76 Cr, surpassing the average EBIT of Rs. -145.38 Cr over the 5 years..